JASMINE WALKER: Open Payments
NPI 1093383747 · DOVER, DE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$823 in 26 payments from 14 companies in 2025. Trend: 2023 $0 · 2024 $807 · 2025 $823
Food & beverage: $823
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 3 | $165 |
| Neurocrine BioSciences, Inc. | 1 | $123 |
| Axsome Therapeutics, Inc. | 2 | $112 |
| Teva Pharmaceuticals USA, Inc. | 4 | $84 |
| Indivior Inc. | 3 | $66 |
| Vanda Pharmaceuticals Inc. | 2 | $57 |
| Lundbeck LLC | 2 | $43 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $41 |
| ABBVIE INC. | 2 | $33 |
| Lilly USA, LLC | 1 | $25 |
Products named: ABILIFY MAINTENA, INGREZZA, Auvelity, SUBLOCADE, AUSTEDO XR, REXULTI, CAPLYTA, ABILIFY ASIMTUFII.
Industry payments across DE — which companies pay providers there.
